Breaking News

Rho Names Principal Bioinformatics Investigator

July 16, 2014

Hall to lead NIAID contracts

David Hall has been appointed principal investigator (PI) specializing in bioinformatics at Rho’s Research Triangle Park headquarters in NC. He will serve as the bioinformatics group leader in the consolidated Division of Allergy, Immunology and Transplantation (DAIT) application of the National Institute of Allergy and Infectious Diseases (NIAID) and of the National Institutes of Health (NIH) proposal.
 
Mr. Hall has more than 12 years of experience in bioinformatics as a principal investigator, general manager, project manager, bioinformatics lead, programmer/analyst, data modeler and software engineer. He joins the company from Syngenta, where he specialized in genome informatics, overseeing the development of genomic data systems and tools supporting trait gene discovery and molecular breeding. He also served as principal investigator at RTI International on two National Institutes of Health (NIH)-funded contracts focusing on bioinformatics and data coordination.

“David’s distinguished bioinformatics background combined with his leadership in genome informatics at a world-class biotechnology company make him a perfect fit for this opportunity,” said Russ Helms, Ph.D., chief executive officer for Rho. “We look forward to David’s contribution as the group leader of bioinformatics and to utilizing his expertise to enhance the scientific reputation of Rho and its 30-year track record of leading federally and commercially funded research.”

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity